CD177 and neoplasm: In the case of cancer, tumor cells can reprogram their microenvironment to turn neutral or anti-tumor cells into tumor supportive elements (Hanahan and Weinberg, 2011; Junttila and de Sauvage, 2013), partly through secreted ligand and cell surface receptor physical interactions (Ramilowski et al., 2015).